Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease

Table 1 Intravenous glycoprotein IIb/IIIa antagonists

	Abciximab	Eptifibatide	Tirofiban	Lamifiban
Structure	Antibody Fab fragment	Cyclic heptapeptide	Non-peptide	Non-peptide
Plasma half-life	10–30 min	∼ 2.5 h	∼ 2 h	∼ 2 h
Excretion	Unknown	∼ 50% renal	39–69% renal	90% renal

ISSN: 1745-6215